Phase 4 Brain Cancer Trial, Recruiting NCT06353529 Sponsor: Hamilton Health Sciences Corporation Condition: Brain Cancer
Back to Brain Cancer

Phase 4 Brain Cancer Trial, Recruiting

NCT06353529
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are having surgery to remove a pituitary adenoma (a type of non-cancerous brain tumour) through the nose

Who may not be able to join:

  • People who have existing long-term pain conditions that require certain medications, including antidepressants (specifically serotonin reuptake inhibitors), benzodiazepines, gabapentin, or opioid-based pain relievers
  • People with a known allergy to the medications used in the nerve block procedure involved in this trial
  • People with a history of long-term heavy alcohol use
  • People with high blood pressure that is not well controlled
  • People with severe kidney or liver disease
  • People with certain heart conditions, including a weakened heart muscle (cardiomyopathy) or ongoing irregular heart rhythms such as permanent atrial fibrillation or other sustained abnormal heart rhythms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Dr. Kesava Reddy, MD, Hamilton Health Sciences Corporatin

Phone: 905-521-2100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Hamilton Health Sciences Corporation
Registry
ClinicalTrials.gov
Start date
25 November 2024
Est. completion
1 April 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Post-operative pain score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov